Related Experiment Video

Updated: Aug 19, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Idiopathic pulmonary fibrosis in patients younger than 50 years

Hassan F Nadrous1, Jeffrey L Myers, Paul A Decker

  • 1Department of Internal Medicine and Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|January 26, 2005
PubMed

Insights

Younger patients with idiopathic pulmonary fibrosis (IPF) do not have a better prognosis than older patients. This study found similar clinical, radiological, and histopathologic features, suggesting early lung transplantation consideration for all IPF patients.

Area of Science:

  • Pulmonology
  • Fibrotic Lung Diseases
  • Idiopathic Pulmonary Fibrosis

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with a poor prognosis.
  • Younger age has been suggested as a favorable prognostic factor in IPF.
  • However, limited data exist on the specific characteristics and outcomes of younger IPF patients.

Purpose of the Study:

  • To investigate clinical, radiological, histopathologic, and prognostic differences in patients diagnosed with idiopathic pulmonary fibrosis (IPF) at a younger age (under 50 years).
  • To compare these features with those typically observed in older IPF cohorts.
  • To inform treatment strategies, particularly regarding lung transplantation.

Main Methods:

  • Retrospective analysis of 22 patients under 50 years old with IPF diagnosed between 1994 and 2000 at the Mayo Clinic.
  • Data collection included clinical, radiological, and histopathologic findings.
  • Pulmonary function tests such as total lung capacity, vital capacity, and diffusing capacity for carbon monoxide were performed.

Main Results:

  • The study cohort comprised 16 men and 6 women with a median age of 45 years.
  • Median survival was 2.1 years, with 1- and 2-year survival rates of 68% and 53%, respectively.
  • Pulmonary function parameters showed significant impairment, with median diffusing capacity at 45.5%.

Conclusions:

  • Contrary to previous suggestions, younger age does not appear to confer a better prognosis in idiopathic pulmonary fibrosis (IPF).
  • Clinical, radiological, and histopathologic features in younger IPF patients were not distinct from those in older patients.
  • Early consideration of lung transplantation is recommended for younger IPF patients due to the observed poor prognosis.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.